Tirzepatide Trends & Statistics
EMARKETER offers market research, trends and statistics for a variety of topics and industries. Here you will find a collection of reports, articles and other resources for Tirzepatide
GLP-1 drugs expected to drive 2026 pharma sales
Article
Jan 23, 2026
Lilly’s tirzepatide is projected to top 2026 sales as pills and uses beyond diabetes and weight loss expand demand.
Eli Lilly’s GLP-1 medication shortage is over
Article
Oct 03, 2024
Eli Lilly’s GLP-1 medication shortage ends: The host of players who offer compounded versions of the blockbuster drugs don’t have to worry—yet.
Powerful data and analysis on nearly every digital topic.
Become a ClientWant more marketing insights?
Sign up for EMARKETER Daily, our free newsletter.
By clicking "Sign Up", you agree to receive emails from EMARKETER (e.g. FYIs, partner content, webinars, and other offers) and accept our Terms of Service and Privacy Policy. You can opt-out at any time.
Thanks for signing up for our newsletter!
You can read recent articles from EMARKETER here.Already have a subscription?Sign In
Access All Charts and Data
- Learn about what technologies are transforming your industry
- Gain exclusive perspectives from top industry leaders
- Access thousands of data sets and forecasts via our iconic charts